Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

Florida Obamacare Enrollees Face $142 Premiums, Forcing Care Trade‑offs
NewsMar 31, 2026

Florida Obamacare Enrollees Face $142 Premiums, Forcing Care Trade‑offs

When enhanced premium tax credits lapsed, Florida's ACA marketplace members saw monthly premiums climb from $0.18 to $142, leaving patients like Kellie Brvenik to choose between life‑saving care and everyday expenses. The surge highlights the fragility of the individual market...

By Pulse
RenovoRx Posts $11.2M FY25 Loss, Sets Mid‑2026 Target for Phase III TIGeR‑PaC Enrollment
NewsMar 31, 2026

RenovoRx Posts $11.2M FY25 Loss, Sets Mid‑2026 Target for Phase III TIGeR‑PaC Enrollment

RenovoRx announced a widened FY25 net loss of $11.2 million, despite its first full year of revenue from the FDA‑cleared RenovoCath device. The company also outlined a timeline to complete enrollment for its Phase III TIGeR‑PaC oncology trial by mid‑2026, a move...

By Pulse
University of Michigan Shows Protein Nanoparticles Deliver Genes to Diverse Human Cells
NewsMar 31, 2026

University of Michigan Shows Protein Nanoparticles Deliver Genes to Diverse Human Cells

Scientists at the University of Michigan have demonstrated that protein‑coated nanoparticles can efficiently deliver DNA and mRNA to liver cancer, kidney and immune cells in vitro, marking a potential shift away from viral vectors in gene therapy. The platform uses...

By Pulse
Galapagos and Gilead Ink $837.5M Framework Deal Tied to Ouro Acquisition
NewsMar 31, 2026

Galapagos and Gilead Ink $837.5M Framework Deal Tied to Ouro Acquisition

Galapagos NV and Gilead Sciences have signed a binding framework agreement that gives Galapagos a 50% share of the $1.675 billion upfront consideration for Gilead’s acquisition of Ouro Medicines. The deal also locks in a $500 million cash pool for Galapagos, including...

By Pulse
Can Damage to a Stressed Cell Be Reversed?
BlogMar 31, 2026

Can Damage to a Stressed Cell Be Reversed?

Soley Therapeutics’ co‑founder and CEO Dr. Yerem Yeghiazarians explained the company’s novel strategy of using small‑molecule drugs to reverse cellular stress rather than targeting a specific virus or gene. The platform aims to restore function in stressed cells implicated in non‑oncology...

By Pharmaceutical Executive (independent trade outlet)
AZ Considers Filings for Long-Acting Strensiq Follow-Up
NewsMar 31, 2026

AZ Considers Filings for Long-Acting Strensiq Follow-Up

AstraZeneca’s Alexion unit intends to file a new long‑acting enzyme replacement therapy, efzimfotase alfa, as a successor to its Strensiq (asfotase alfa) for hypophosphatasia (HPP). Phase 3 data showed the drug met primary endpoints in pediatric patients but failed to achieve...

By pharmaphorum
New CDC Director Likely Powerless Amid Dysfunction
SocialMar 31, 2026

New CDC Director Likely Powerless Amid Dysfunction

Solid editorial that will be immediately ignored. The new CDC Director should do a lot of things. They won’t, if one is ever nominated, because the CDC isn’t functioning any more

By Angela Rasmussen
From Mandates to Medicine Cabinets: Dr. Peter McCullough’s Revolt Against the Bio-Pharmaceutical Complex
PodcastMar 31, 20260 min

From Mandates to Medicine Cabinets: Dr. Peter McCullough’s Revolt Against the Bio-Pharmaceutical Complex

In this episode of American Sunrise, Dr. Peter McCullough critiques recent attempts by Robert F. Kennedy Jr. and the CDC to reduce the U.S. childhood vaccine schedule, arguing that the process excluded major medical societies and was therefore legally vulnerable. He contends that the...

By FOCAL POINTS (Courageous Discourse)
Noveva Selected as Electronic Document Management Partner for Velindre’s New Cancer Centre
NewsMar 31, 2026

Noveva Selected as Electronic Document Management Partner for Velindre’s New Cancer Centre

Velindre University NHS Trust has chosen Noveva Software Group’s CCube Cloud to power the electronic document management system for Wales’ new flagship cancer centre, slated to open in spring 2027. The cloud‑based platform will replace on‑site paper storage, integrating with...

By HTN – Health Tech Newspaper (UK)
Union Budget Targets 2.5 Lakh Trained Professionals
NewsMar 31, 2026

Union Budget Targets 2.5 Lakh Trained Professionals

India’s Union Budget raised the health ministry’s allocation by 10% to over Rs 1.06 lakh crore—approximately $13 billion—signalling a major fiscal push for the sector. The plan earmarks training for 100,000 allied‑health professionals and 150,000 caregivers over the next five years. Funding will also...

By HR Katha (India)
Latest Digital Maturity Assessment Data Reveals Trusts Reporting Lowest Digital Maturity
NewsMar 31, 2026

Latest Digital Maturity Assessment Data Reveals Trusts Reporting Lowest Digital Maturity

The NHS Digital Maturity Assessment 2025 released scores for 47 digital domains, revealing the lowest‑performing trusts. Torbay and South Devon NHS Foundation Trusts (acute and community) sit at the bottom with a 1.5 rating, a slight rise from 1.4 in...

By HTN – Health Tech Newspaper (UK)
Blackstone Closes $6.3bn Life Sciences Fund
NewsMar 31, 2026

Blackstone Closes $6.3bn Life Sciences Fund

Blackstone announced the closing of its newest life sciences fund at $6.3 billion, topping the original target. The vehicle will back biotech, pharmaceutical and medical‑technology companies from seed to growth stages. Investor enthusiasm for health‑tech has surged since the pandemic, allowing...

By Private Equity Wire
Healing Wounded Skin without Scarring? Preclinical Research Shows Promise
BlogMar 31, 2026

Healing Wounded Skin without Scarring? Preclinical Research Shows Promise

Harvard researchers uncovered that post‑natal skin scarring is driven by fibroblast‑produced Cxcl12, which triggers excessive nerve growth that blocks full tissue regeneration. By deleting Cxcl12 or applying Botox to suppress local nerve signaling, mice healed wounds without scars, restoring all...

By BioTechniques (independent journal site)
Deep Dive: Discussing Neighbourhood Health with Fay Johnstone, Maidstone and Tunbridge Wells and Christopher Malone, Luscii
NewsMar 31, 2026

Deep Dive: Discussing Neighbourhood Health with Fay Johnstone, Maidstone and Tunbridge Wells and Christopher Malone, Luscii

Luscii’s flexible digital platform now underpins Maidstone and Tunbridge Wells NHS Trust’s acute virtual ward, enabling remote monitoring across more than 150 conditions. Matron Fay Johnstone’s team has cared for over 4,000 patients at home, delivering hospital‑level care while freeing...

By HTN – Health Tech Newspaper (UK)
Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
NewsMar 31, 2026

Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators

In August, the Trump administration ordered states to re‑verify Medicaid enrollment for individuals whose immigration status was unclear. Five states that reported back found only a handful of undocumented enrollees were removed, with Pennsylvania and Colorado terminating none, Texas 77,...

By KFF Health News
Is Trump Killing the Heralded U.S. Effort to Help the World Battle HIV?
NewsMar 31, 2026

Is Trump Killing the Heralded U.S. Effort to Help the World Battle HIV?

The State Department has transferred only about $640 million of the $4.6 billion PEPFAR budget to the CDC, leaving a roughly $660 million shortfall for the fiscal year. The Trump administration’s shift from USAID to a CDC‑led model and its new memorandum‑of‑understanding (MOU)...

By Science (AAAS)  News
UBriGene and Cellinfinity BIO Collaborate to Accelerate in Vivo CAR-T Therapies
NewsMar 31, 2026

UBriGene and Cellinfinity BIO Collaborate to Accelerate in Vivo CAR-T Therapies

uBriGene Biosciences has entered a strategic partnership with Cellinfinity BIO to accelerate the development of in‑vivo CAR‑T therapies for both solid tumors and hematologic cancers. The collaboration will apply uBriGene’s LVV Turbo platform, which delivers up to 80% purification recovery...

By Pharmaceutical Technology (GlobalData)
UBriGene and Cellinfinity BIO Collaborate to Accelerate in Vivo CAR-T Therapies
NewsMar 31, 2026

UBriGene and Cellinfinity BIO Collaborate to Accelerate in Vivo CAR-T Therapies

uBriGene Biosciences has entered a strategic partnership with Cellinfinity BIO to fast‑track in‑vivo CAR‑T programs for both solid and hematologic cancers. The deal leverages uBriGene’s LVV Turbo platform, which delivers GMP‑grade lentiviral vectors with up to 80% purification recovery and...

By Hospital Management
ACC 2026: Lorundrostat Lowers BP but Raises Hyperkalemia Risk
NewsMar 31, 2026

ACC 2026: Lorundrostat Lowers BP but Raises Hyperkalemia Risk

At the 2026 ACC Scientific Session, Brazilian investigators presented a meta‑analysis of three placebo‑controlled trials (1,060 patients) evaluating lorundrostat in uncontrolled hypertension. Lorundrostat 50 mg reduced systolic blood pressure by 9.08 mm Hg and diastolic by 3.48 mm Hg, while the 100 mg dose achieved an...

By Pharmaceutical Technology (GlobalData)
Clinical Efficacy of Low-Level Laser Therapy as an Adjunct to Non-Surgical Treatment of Peri-Implantitis: A Systematic Review and Meta-Analysis
NewsMar 31, 2026

Clinical Efficacy of Low-Level Laser Therapy as an Adjunct to Non-Surgical Treatment of Peri-Implantitis: A Systematic Review and Meta-Analysis

A systematic review and meta‑analysis of 15 randomized trials involving 644 patients and 742 implants examined low‑level laser therapy (LLLT) and antimicrobial photodynamic therapy (aPDT) as adjuncts to non‑surgical debridement for peri‑implantitis. The analysis found modest but statistically significant reductions...

By Research Square – News/Updates
Comparison of Capillary Microsampling and Venous Blood for Multi-Pathogen Serosurveillance
NewsMar 31, 2026

Comparison of Capillary Microsampling and Venous Blood for Multi-Pathogen Serosurveillance

A pre‑print study compared capillary dried blood spot (DBS) microsampling—including filter‑paper punches and Mitra volumetric absorptive microsamplers—with venous plasma for multiplex serosurveillance of seven vaccine‑preventable diseases. The analysis showed strong agreement for six pathogens, with ≥93% of paired measurements within...

By Research Square – News/Updates
PhilHealth to Implement SPA Generator as Part of Digitalization Push Starting April 1
NewsMar 31, 2026

PhilHealth to Implement SPA Generator as Part of Digitalization Push Starting April 1

The Philippine Health Insurance Corporation (PhilHealth) will launch a Statement of Premium Account (SPA) Generator on April 1 for self‑paying members. Under the new “No SPA, No Payment” rule, members must create a QR‑coded SPA before any contribution can be processed....

By Manila Bulletin – Business
Imaging Interpretation Turnaround Times More than Double over a Decade
NewsMar 31, 2026

Imaging Interpretation Turnaround Times More than Double over a Decade

Imaging interpretation turnaround times more than doubled between 2014 and 2023, climbing from roughly 2 hours 11 minutes to 4 hours 37 minutes – a 113% increase. The study of 2.6 million Medicare imaging claims shows the steepest jumps in CT (318%) and MR (256%) scans. A...

By Radiology Business
Merck Reports P-III (CORALreef AddOn) Trial Data on Enlicitide Decanoate in Hypercholesterolemia
NewsMar 31, 2026

Merck Reports P-III (CORALreef AddOn) Trial Data on Enlicitide Decanoate in Hypercholesterolemia

Merck presented Phase III CORALreef AddOn trial results for enlicitide decanoate, an oral PCSK9 inhibitor, in hypercholesterolemic adults on statins. At eight weeks, the drug lowered LDL‑C by 64.6%, outperforming bempedoic acid, ezetimibe and their combination. It also achieved 54.6%...

By PharmaShots
Humber Teaching Receives NHSE Funding to Lead on Roll-Out of NHS App Functionality
NewsMar 31, 2026

Humber Teaching Receives NHSE Funding to Lead on Roll-Out of NHS App Functionality

Humber Teaching NHS Foundation Trust has secured NHS England funding to spearhead the rollout of appointment‑management functionality within the NHS App, a capability that will be extended to 11 other trusts using the SystmOne electronic patient record system. The new...

By HTN – Health Tech Newspaper (UK)
CEO of America’s Largest Public Hospital System Says He’s Ready to Replace Radiologists with AI
NewsMar 31, 2026

CEO of America’s Largest Public Hospital System Says He’s Ready to Replace Radiologists with AI

Mitchell H. Katz, CEO of NYC Health + Hospitals, announced the system is prepared to let artificial‑intelligence algorithms perform first‑read radiology interpretations once state regulations allow. He highlighted AI’s growing role in mammogram and X‑ray analysis and the potential for...

By Radiology Business
Leeds Teaching Hospitals Secures Major NIHR Capital Research Infrastructure Funding to Accelerate World‑leading Research
BlogMar 31, 2026

Leeds Teaching Hospitals Secures Major NIHR Capital Research Infrastructure Funding to Accelerate World‑leading Research

Leeds Teaching Hospitals has secured £1.5 million (≈ $1.9 million) of NIHR Capital Research Infrastructure funding to expand its research capabilities. The grant will finance a pioneering histotripsy platform, AI‑enabled handheld cardiac ultrasound, a simulated surgical suite for sustainability testing, and upgraded digital...

By Health Tech World
Singapore's CDA to Roll Out Enhanced Precautionary Measures Against Measles From 1 April 2026
NewsMar 31, 2026

Singapore's CDA to Roll Out Enhanced Precautionary Measures Against Measles From 1 April 2026

Singapore’s Communicable Diseases Agency will implement enhanced precautionary measures against measles starting 1 April 2026. The policy follows detection of three genetically linked cases in January and 12 additional cases through March, most of whom were unvaccinated. Measures include mandatory testing for...

By Human Resources Online (Asia)
Healthcare Reclaims Top Spot Among U.S. Domestic Worries
NewsMar 31, 2026

Healthcare Reclaims Top Spot Among U.S. Domestic Worries

A new Gallup poll released March 31 shows healthcare is the top domestic worry for 61% of Americans, reclaiming the lead from the economy. Overall anxiety about the 16 surveyed issues fell to an average 43%, the lowest level since early 2020,...

By Gallup – Workplace
Hospital System Investing Nearly $23M to Expand Interventional Radiology Services
NewsMar 31, 2026

Hospital System Investing Nearly $23M to Expand Interventional Radiology Services

BayCare, a west‑central Florida hospital system, is allocating roughly $22.5 million to centralize and expand interventional radiology (IR) services at St. Anthony’s Hospital in St. Petersburg. The investment will fund two new bi‑plane suites, 12 pre‑ and post‑procedure bays, and dedicated patient waiting...

By Radiology Business
Role of Exercise Physiologists in Mental Health Support and Recovery: 2026 Exercise and Sports Science Australia (ESSA) Consensus Statement
NewsMar 31, 2026

Role of Exercise Physiologists in Mental Health Support and Recovery: 2026 Exercise and Sports Science Australia (ESSA) Consensus Statement

Exercise and Sports Science Australia (ESSA) has released a 2026 Consensus Statement that formally defines the role, scope and integration pathways for accredited exercise physiologists (EPs) within mental‑health services. Developed through a four‑step Delphi process with 24 experts and endorsed...

By British Journal of Sports Medicine (BJSM)
Post-Exertional Malaise and the Myth of Cardiac Deconditioning: Rethinking the Pathophysiology of Long Covid
NewsMar 31, 2026

Post-Exertional Malaise and the Myth of Cardiac Deconditioning: Rethinking the Pathophysiology of Long Covid

Post‑exertional malaise (PEM) affects roughly 80% of long‑COVID patients, triggering delayed symptom flare‑ups that can last days or weeks. New research argues that cardiac abnormalities seen in these patients—such as preload failure, inflammatory scarring, and endothelial damage—are distinct from classic...

By British Journal of Sports Medicine (BJSM)
Optimising Exercise Training Prescription in Cardiac Rehabilitation Beyond Clinical Guideline Recommendations
NewsMar 31, 2026

Optimising Exercise Training Prescription in Cardiac Rehabilitation Beyond Clinical Guideline Recommendations

The article reviews current cardiac rehabilitation exercise guidelines and proposes a more individualized, higher‑intensity prescription. It highlights that high‑intensity interval training (HIIT) and interval‑based resistance protocols can boost peak VO₂ and functional capacity without raising adverse events when supervised. The...

By British Journal of Sports Medicine (BJSM)
ChAnGe Project: Cardiopulmonary and Strength Analysis in Gender Transition
NewsMar 31, 2026

ChAnGe Project: Cardiopulmonary and Strength Analysis in Gender Transition

The ChAnGe project, led by Dr. Marco Vecchiato at the University Hospital of Padova, investigates cardiopulmonary function and muscular strength in transgender and gender‑diverse (TGD) individuals beginning gender‑affirming hormone therapy (GAHT). Since November 2024 the study has enrolled 16 TGD participants...

By British Journal of Sports Medicine (BJSM)
Seed Medical Launches Psychiatric Services as HK Mental Health Rises
NewsMar 31, 2026

Seed Medical Launches Psychiatric Services as HK Mental Health Rises

Hong Kong's mental health indicators have reached a critical red‑light level, with depression and anxiety scores climbing to 7.27 and 5.9, the highest since 2012. A recent survey shows 55 % of residents hesitate to seek professional help, while AI assistants...

By Vietnam Investment Review (VIR)
Teva Advances Biosimilars Portfolio with Ponlimsi (Denosumab) FDA Approval and Dual Omalizumab Filing Acceptance
NewsMar 31, 2026

Teva Advances Biosimilars Portfolio with Ponlimsi (Denosumab) FDA Approval and Dual Omalizumab Filing Acceptance

Teva Pharmaceutical received U.S. FDA approval for Ponlimsi, a biosimilar to Amgen’s Prolia (denosumab), covering all approved indications. The approval was granted after extensive analytical and clinical studies demonstrated comparable efficacy, safety, and immunogenicity to the reference product. In parallel,...

By PharmaShots
Orthodontic Treatment in Adulthood: What Really Changes?
NewsMar 31, 2026

Orthodontic Treatment in Adulthood: What Really Changes?

Adult orthodontic treatment is increasingly common as modern technologies like clear aligners and ceramic braces make discreet, effective tooth movement possible well beyond adolescence. While teeth can shift at any age, successful outcomes hinge on healthy gums, adequate bone density,...

By Healthcare Guys
Where to Find the Best Invisalign Provider in Thornton
NewsMar 31, 2026

Where to Find the Best Invisalign Provider in Thornton

Choosing Invisalign is only half the journey; selecting a qualified provider determines treatment success. In Thornton, providers differ in experience, digital planning, communication, and post‑treatment support. The article outlines criteria such as case volume, use of intraoral scanners, clear timeline...

By Healthcare Guys
How Medical Technology Is Improving the Diagnosis of Binocular Vision Problems
NewsMar 31, 2026

How Medical Technology Is Improving the Diagnosis of Binocular Vision Problems

Medical technology is transforming how clinicians diagnose binocular vision disorders, which often hide behind generic eye‑strain complaints. Traditional eye exams focus on static acuity, missing dynamic issues like accommodative and vergence dysfunction that cause headaches, dizziness, and reading difficulty. New...

By Healthcare Guys
Major Upgrade for Musgrove Park Hospital’s Nuclear Medicine Department
BlogMar 31, 2026

Major Upgrade for Musgrove Park Hospital’s Nuclear Medicine Department

Musgrove Park Hospital in Somerset has reopened its Nuclear Medicine department after a comprehensive refurbishment and the installation of a state‑of‑the‑art SPECT/CT scanner. The new hybrid system delivers high‑resolution 3‑D images that combine functional and anatomical data, expanding the range...

By Health Tech World
Dr. Nishi Patel Discusses Modern Diagnostic Tools in Cardiology: From Echocardiograms to Cardiac MRIs
NewsMar 31, 2026

Dr. Nishi Patel Discusses Modern Diagnostic Tools in Cardiology: From Echocardiograms to Cardiac MRIs

Dr. Nishi Patel outlines how echocardiography and cardiac MRI together shape modern cardiology in the United States. Echocardiograms serve as a low‑cost, widely available first‑line tool that provides real‑time functional data, while cardiac MRI delivers high‑resolution tissue characterization for complex...

By Healthcare Guys
Bioinspired Anti‐VEGF Peptide Nanoparticle with Immune Regulating and Corneal Epithelium Penetration Capability for Corneal Neovascularization Therapy
NewsMar 31, 2026

Bioinspired Anti‐VEGF Peptide Nanoparticle with Immune Regulating and Corneal Epithelium Penetration Capability for Corneal Neovascularization Therapy

Researchers have engineered a bioinspired nanoparticle that co‑assembles an anti‑VEGF peptide with copper ions, adds a ROS‑scavenging moiety and a cell‑penetrating peptide, and achieves deep corneal delivery. The formulation extends ocular residence to roughly 70 minutes and reaches 300 µm in a...

By Small (Wiley)
Large‐Scale Ferroelectric Ceramic Wafer Achieved by Sintering Strategies for Sensitive High‐Temperature Self‐Powered X‐ray Detection
NewsMar 31, 2026

Large‐Scale Ferroelectric Ceramic Wafer Achieved by Sintering Strategies for Sensitive High‐Temperature Self‐Powered X‐ray Detection

Researchers have fabricated a large‑scale ferroelectric ceramic wafer (PNN‑PZT) using solid‑state sintering, achieving record‑high sensitivity for self‑powered X‑ray detection. At 150 °C the detector reaches 248 µC Gy⁻¹ cm⁻² sensitivity and a detection limit of 6.76 nGy s⁻¹, surpassing commercial amorphous selenium devices. The material exhibits...

By Small (Wiley)
Healthcare’s Quiet Dependence on the “Possimpible”
BlogMar 31, 2026

Healthcare’s Quiet Dependence on the “Possimpible”

Healthcare now leans on clinicians to deliver care that exceeds system capacity, filling gaps with unpaid, after‑hours tasks. This invisible labor fuels a chronic burnout crisis rooted in flawed system design rather than personal resilience. The article argues that without...

By The Health Care Blog
Association Between Pre-Operative Computed Tomography-Based Adipose Tissue Quantification and Post-Transplant Dyslipidemia in Renal Transplantation Recipients
NewsMar 31, 2026

Association Between Pre-Operative Computed Tomography-Based Adipose Tissue Quantification and Post-Transplant Dyslipidemia in Renal Transplantation Recipients

A 2026 Frontiers in Nutrition study of 250 kidney‑transplant recipients found that pre‑operative visceral adipose tissue (VAT) measured by CT strongly predicts post‑transplant dyslipidemia. While BMI and other fat depots correlated with lipid abnormalities in univariate tests, multivariate models identified...

By Frontiers in Nutrition
Low Vitamin D Status and 10-Year Dementia Risk in Sensory-Impaired Adults: A Propensity Score-Matched Cohort Study
NewsMar 31, 2026

Low Vitamin D Status and 10-Year Dementia Risk in Sensory-Impaired Adults: A Propensity Score-Matched Cohort Study

Researchers analyzed over 158,000 adults aged 50+ with vision or hearing impairment using the TriNetX database. After propensity‑score matching, those with vitamin D deficiency (<20 ng/mL) faced a 55 % higher hazard of developing dementia over ten years compared with individuals with...

By Frontiers in Nutrition
Application of an ACE Star Model–Based Evidence-Based Enteral Nutrition Management Protocol in Neurocritical Care Patients
NewsMar 31, 2026

Application of an ACE Star Model–Based Evidence-Based Enteral Nutrition Management Protocol in Neurocritical Care Patients

Researchers applied the ACE Star evidence‑based model to create a standardized enteral nutrition protocol for neurocritical care patients in a Chinese tertiary ICU. Compared with a historical control, the protocol lowered feeding intolerance incidence from 70% to 31% and boosted...

By Frontiers in Nutrition
L–Carnitine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms and Therapeutic Potential
NewsMar 31, 2026

L–Carnitine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms and Therapeutic Potential

A new review in *Metabolism* outlines how L‑carnitine may counteract metabolic dysfunction‑associated steatotic liver disease (MASLD), which now afflicts roughly one‑third of the global population. The authors detail L‑carnitine’s role in boosting mitochondrial fatty‑acid oxidation, improving insulin sensitivity, and dampening...

By Frontiers in Nutrition
'Something Wasn't Right': Wrong Sperm Given to UK Families by IVF Clinics in Northern Cyprus
NewsMar 31, 2026

'Something Wasn't Right': Wrong Sperm Given to UK Families by IVF Clinics in Northern Cyprus

A BBC investigation found that two British families who underwent IVF at Dogus IVF Centre in northern Cyprus received sperm from different, undisclosed donors, meaning their children are not biologically related. DNA testing confirmed neither child was conceived with the...

By BBC News – Health